Heritable Genome Editing
SELECT VIDEOS, INTERVIEWS & PODCASTS
- Tromberg, F. (27 Sep 2019). Life, the law and legal issues. Interview with Françoise Baylis. Pure Radio Production, 103.7 FM & 1320 AM, Jacksonville FL.
- Spear, M. (27 Sep 2019). The human genome belongs to you. Interview with Françoise Baylis. GenomeAlberta.
- Stein, R. (22 Aug 2019). Scientists attempt controversial experiment to edit DNA in human sperm using CRISPR. Interview with June Wang and Françoise Baylis. NPR /SDPB Radio.
- Bresnahan, R. (9 Jul 2019). Canadian bioethicist calls to prevent deafness in gene-edited babies 'offensive'. Interview with Françoise Baylis. As It Happens - CBC Radio.
- Lopes, R. (28 Nov 2018). The ethics of CRISPR-cas9 gene editing technology. Interview with Françoise Baylis.The Dissenter.
- CTV staff. (26 Nov 2018). 'You can't just pretend to be God.' Interview with Françoise Baylis. CTV News.
SELECT MEDIA ARTICLES
- d'Entremont, Y. (14 Sep 2019). From curing disease to designer babies, Halifax prof's book urges caution in evolving world of gene editing. The Star.
- Mullin, R. (28 Aug 2019). Researchers issue statement of principles on gene editing. Chemical & Engineering News, 97(34): online.
- Stein, R. (22 Aug 2019). Scientists attempt controversial experiment to edit DNA in human sperm using CRISPR. NPR.
- Buck, G. (8 Jul 2019). 'It's totally irresponsible': Canadian ethicist slams rogue Russian's plan to edit human embryos. National Post.
- Keshavan, M. (8 Sept 2017). He [Shoukhrat Mitalipov] edited a human embryo, with startling results. Now he’s toiling to understand just what happened. STAT News.
SELECT BLOGS
- Baylis, F. (18 Sep 2018). The CRISPR dream. Impact Ethics.
- Bayliis, F. (3 Apr 2019). Why avoid the "M-word" in human genome editing? Bioethics Forum.
- Baylis, F., & Darnovsky, M. (17 Jan 2019). Scientists disagree about the ethics and governance of human germline editing. Bioethics Forum.
- Getz, L., Dellaire, G., & Baylis, F. (10 Dec 2018). Jianku He: a sorry tale of high-stakes science. Bioethics Forum.
- Baylis, F, Dellaire, G., & Getz, L. (27 Nov 2018). Why we are not ready for genetically designed babies. The Conversation.
- Baylis, F. (26 Nov 2018). First CRISPR babies: where are our ethics? Impact Ethics.
- Baylis, F., & Cattapan, A. (2 Oct 2017). Canada’s prohibition on altering the human genome. Impact Ethics.
- Baylis, F. (1 Oct 2017). Genome editing of human embryos broadens ethics discussion. The Conversation.
Baylis, F. (1 Aug 2017). Human gene editing: We should all have a say. The Conversation.
- Baylis, F. (17 Feb 2017). Human germline genome editing: An ‘impressive’ sleight of hand? Impact Ethics.
- Baylis, F. (12 Feb 2016). Human gene editing: A global discussion. Impact Ethics.
- Baylis, F. (3 Feb 2016). A cautious approach to mitochondrial replacement. Impact Ethics.
SELECT PUBLICATIONS
- Baylis, F. (2019). Human genome editing: Our future belongs to all of us. Issues in Science and Technology, 35(3), 42-44.
- Lander, E., Baylis, F., Zhang, F. et al. (2019). Adopt a moratorium on heritable genome editing. Nature. 567, 165-168. DOI: 10.1038/d41586-019-00726-5.
- Baylis, F. (2019). Questioning the proposed translational pathway for germline genome editing. Nature Human Behaviour, 3(200). DOI: 10.1038/s41562-019-0544-3.
- Saha, K., Hurlbut, J.B., Jasanoff, S., Ahmed, A., Appiah, A., Bartholet, E., Baylis, F. et al. (2018). Building capacity for a global genome-editing observatory: Institutional design. Trends in Biotechnology, DOI: 10.1016/j.tibtech.2018.04.008. [Epub ahead of print].
- Hurlbut, J.B., Jasanoff, S., Saha, K., Ahmed, A., Appiah, A., Bartholet, E., Baylis, F. et al. (2018). Building capacity for a global genome-editing observatory: Conceptual challenges. Trends in Biotechnology, 36(7), 639-641. DOI: 10.1016/j.tibtech.2018.04.009
- Baylis, F. (2018). COUNTERPOINT: The potential harms of human gene editing using CRISPRCas9. Clinical Chemistry, 64(3), 489-491. DOI: 10.1373/clinchem.2017.278317
- Baylis, F., & McLeod, M. (2017). First-in-human phase 1 CRISPR gene editing cancer trials: are we ready? Current Gene Therapy, 17(4), 309-319. DOI: 10.2174/1566523217666171121165935
- Baylis, F. (2017). Human germline genome editing and broad societal consensus. Nature Human Behaviour, 1, 0103. DOI: 10.1038/s41562-017-0103
- Baylis, F. (2017). Human nuclear genome transfer (so-called mitochondrial replacement): clearing the underbrush. Bioethics, 31(1), 7-19. DOI:10.1111/bioe.12309
- Vasiliou, S.K., Diamandis, E.P., Church, G.M, Greely, H.T., Baylis, F., Thompson, C., & Schmitt-Ulms, G. (2016). CRISPR-Cas9 system: opportunities and concerns. Clinical Chemistry 62(10), 1304-11. DOI: 10.1373/clinchem.2016.263186
- Baylis, F. (2016) ‘Broad societal consensus’ on human germline editing. Harvard Health Policy Review, 15(2), 19-23.
- Baylis, F. (2016). Mitochondrial replacement techniques: ethical, social and policy considerations. RSC Reports from Abroad.
- Baylis, F. and Rossant, J. (2016). This CRISPR moment: Editing human DNA the way we edit text – are we ready? Walrus Magazine, April, 15-17.
- Organizing Committee for the International Summit on Human Gene Editing. (3 Dec 2015). On human gene editing: international summit statement. The National Academies of Sciences, Engineering, Medicine.
- Committee on Science, Technology, and Law Policy and Global Affairs. (Meeting in brief, 1-3 Dec 2015). International summit on human gene editing: a global discussion. Washington, DC: The National Academies Press.
SELECT POLICY CONTRIBUTIONS
- Baltimore, D., Baylis, F., Berg, P. et al. (3 Dec 2015). On human gene editing: International Summit statement. The National Academies of Sciences, Engineering & Medicine.
- Petropanagos, A., & Mariscal, C. (20 Feb 2016). Response to genome editing: open call for evidence. Nuffield Council on Bioethics.
